News And Announcements
Europe open: Shares soar as Omicron fears recede
European shares opened sharply higher on Tuesday as investors continued to punt on the new Omicron variant of the coronavirus may not be as severe as first thought.
Paragon Banking reports record profits, confirms new £50m buyback
Paragon Banking Group reported record profits in its final results on Tuesday, thanks to strong lending and margin growth, with its underlying profit before tax rising 61. 8% to £192. 4m.
AstraZeneca strikes development and commercialisation deal with Ionis
Drugmaker AstraZeneca has struck a deal with Ionis Pharmaceuticals that will see the pair work together to develop and commercialise its investigational medicine Eplontersen.
GSK-Vir drug works against all Omicron variants - study
GlaxoSmithKline and Vir Biotechnology on Tuesday said their antibody Covid-19 treatment was effective against all mutations of the Omicron variant, according to early-stage studies.
Liontrust to acquire Majedie Asset Management in £120m deal
Fund manager Liontrust Asset Management had entered into a conditional sale and purchase agreement to purchase British asset manager Majedie Asset Management for as much as £120. 0m.
BAT holds guidance as new product popularity rises
British American Tobacco maintained annual profit and sales guidance as more people switched to its vaping and oral nicotine products.
Ferguson raises expectations after strong first quarter
Ferguson said its expectations for annual results had increased after the plumbing and heating distributor reported a surge in first-quarter profit.